Blis Technologies has reported another half year loss, but says trading revenue continued to improve despite a tough global operating environment.
The biotechnology firm lost $403,000 in the six months to the end of September, compared to $180,000 in the same period the previous year.
Revenue rose 8% to $1.2 million.
The company will not pay a dividend.
